APA (7th ed.) Citation

Dicken, J. E. (2023). Medicare Part D: CMS should monitor effects of rebates on drug coverage and spending: Testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives. United States Government Accountability Office.

Chicago Style (17th ed.) Citation

Dicken, John E. Medicare Part D: CMS Should Monitor Effects of Rebates on Drug Coverage and Spending: Testimony Before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives. Washington, DC: United States Government Accountability Office, 2023.

MLA (9th ed.) Citation

Dicken, John E. Medicare Part D: CMS Should Monitor Effects of Rebates on Drug Coverage and Spending: Testimony Before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives. United States Government Accountability Office, 2023.